BERLIN -- Bayer AG unveiled on Wednesday billions in new costs cuts to offset falling demand in agricultural products -- the market on which it had made a huge bet with its acquisition of Monsanto. The German chemicals and pharmaceuticals company said the coronavirus pandemic would hit its crop-science business harder than anticipated as prices for various crops fell, consumption of biofuel decreased and competition in the soy market intensified.